Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OLIGYNE-10 RT: An International, Multicenter, Ambispective Observational Registry of Radiotherapy for Oligometastatic Gynecologic Cancers With Up to 10 Active Metastatic Lesions, Stratified by PET Imaging

NCT07883798 is registered in ClinicalTrials.gov with Affidea Nu-med Center of Oncological DIagnostics and Therapy as lead sponsor.

NCT NCT07883798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07883798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OLIGYNE-10 RT: An International, Multicenter, Ambispective Observational Registry of Radiotherapy for Oligometastatic Gynecologic Cancers With Up to 10 Active Metastatic Lesions, Stratified by PET Imaging
Lead sponsor
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase
Observational
Overall status
Recruiting
Start date
October 6, 2026
Completion date
December 31, 2036
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, fallopian tube cancer, gynecologic cancer, ovarian cancer, primary peritoneal cancer, uterine cancer, uterine sarcoma, vaginal cancer, vulvar cancer